Cipla | CIPLA - Fremdkapital

Aktienkurs
1,319.00
Täglich Wechseln
12.50 0.96%
Monatlich
7.74%
Jährlich
-14.91%
Q2 Prognose
1,266.51




Fremdkapital Veränderung Datum
aTyr Pharma USD 12.51M 12.11M 2025-12
Bio Path USD 0 0 2025-03
Brainstorm Cell Therapeutics USD 0 0 2025-03
Capricor Therapeutics USD 3.38M 0 2025-03
Cara Therapeutics USD 0 0 2025-03
Cipla INR 2.98B 454.6M 2025-09
Dr.Reddys Laboratories INR 11.61B 29M 2025-12
Esperion Therapeutics USD 457.65M 9.5M 2025-12
Immunic USD 0 0 2024-06
Infinity Pharmaceuticals USD 0 0 2022-06
Minerva Neurosciences USD 0 86.58M 2024-09
Nektar Therapeutics USD 63.16M 44.35M 2025-12
Sangamo BioSciences USD 0 0 2022-06
Sun Pharmaceuticals INR 3.62B 36.4M 2025-09
TherapeuticsMD USD 0 0 2022-03
UPL INR 182.37B 10.19B 2025-09